RAP-219 for epilepsies, partial

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 21 Oct 2025: Trial registered, NCT07219407
  2. 15 Dec 2025: Trial started, NCT07219407

The trials

NCT07219407: A Long-term Study of the Safety and Effectiveness of RAP-219 in Adults With Focal Onset Seizures

State
Under way
Phase
Phase 2
People
30 planned
Started
15 Dec 2025
Primary completion
3 Feb 2028
Arms
RAP-219
Results
None posted
  1. 21 Oct 2025: Trial registered
  2. 15 Dec 2025: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.